0.66
0.92%
0.006
Finanzdaten der Passage Bio Inc-Aktie (PASG)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Income/Loss |
2.15%
-18.05
|
-18.45 | -28.67 | -25.39 | -35.88 |
Income/Loss From Continuing Operations Before Tax |
0.28%
-16.71
|
-16.76 | -27.11 | -23.86 | -34.34 |
Income/Loss From Continuing Operations After Tax |
0.28%
-16.71
|
-16.76 | -27.11 | -23.86 | -34.34 |
Net Income/Loss
|
0.28%
-16.71
|
-16.76 | -27.11 | -23.86 | -34.34 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
123.56K%
56.30
|
0.0455 | 54.79 | 54.68 | 54.62 |
Diluted Average Shares |
123.56K%
56.30
|
0.0455 | 54.79 | 54.68 | 54.62 |
Basic Earnings Per Share |
0.00%
-0.30
|
-0.30 | -0.49 | -0.44 | -0.63 |
Diluted Earnings Per Share |
0.00%
-0.30
|
-0.30 | -0.49 | -0.44 | -0.63 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):